| Date | Title |
|---|---|
| 15 Nov 2022 |
IP Group plc Becomes most active investor in Australian university spin-outs |
| 31 Aug 2022 |
IP Group plc Portfolio company Istesso announces initiation of Phase 2b trial of lead drug MBS2320 |
| 30 Aug 2022 |
IP Group plc Recommended cash acquisition of portfolio company Diurnal Group plc by Neurocrine Biosciences, Inc |
| 03 Aug 2022 |
IP Group plc |
| 02 Aug 2022 |
IP Group plc |
| 22 Jun 2022 |
IP Group plc Launches ‘Kiko Ventures’ platform to deepen its support for transformative climate technology |
| 14 Jun 2022 |
IP Group plc |
| 26 Apr 2022 |
Blog |
| 11 Apr 2022 |
IP Group plc & Parkwalk IP Group plc & Parkwalk co-lead $11m (£8.4m) Series A round in GripAble |
| 05 Apr 2022 |
IP Group plc |
Loadmore